Conceptual
Single-cell genomics (SCG) is a quickly developing and presently progressively more settled methodology wherein genomic innovations (i.e., that survey nucleic acids like DNA or RNA) are applied at the degree of single-cells, rather than at the level of a whole cell populace.
The fourth release of this report audits the market size, division, development and patterns of the SCG market. We survey the SCG market across 7 sections and 33 subsegments: client (e.g., the scholarly community, biopharma, applied business sectors, clinical), work process step (e.g., cell seclusion, test planning, genomic examination), scientific innovation (e.g., PCR, qPCR, microarray, cutting edge sequencing, other), field-of-review (e.g., oncology, fundamental cell science, undifferentiated organism science, microbial science, nervous system science, immunology, other), application (e.g., genomic variety, subpopulation portrayal, coursing cancer cells, cell separation/reprograming, technique, other), item type (e.g., instruments, reagents) and topography (e.g., U.S., Europe, Japan, China, Asia-Pacific, ROW). For every one of these sections, we give an expected market size and development from 2015 to 2023, just as key development drivers and arbitrators.
We audit key elements driving future development including 1) Increasing business accessibility of new applications past RNA-seq, including multiomics (e.g., ATAC-seq, CITE-seq) and utilitarian examines, 2) 10X Genomics driving extra applications on huge and developing introduce base, 3) Large-scale, very much financed drives, similar to the Human Cell Atlas, 4) New instruments that can robotize and improve the strong tissue to cells/cores suspension planning, taking care of high-throughput machines. Then again, we talk about key elements directing development including 1) Challenges in information examination and information joining as the single-cell concentrate on sizes increment and single-cell multiomics interest grows, 2) High sequencing cost comparative with earlier logical advances.
Also, we incorporate result from an essential examination crusade across 25 single-cell specialists in scholarly community, biopharma, and clinical settings. We catch current and expected spend, analyte patterns (e.g., RNA, DNA, multiomics), stage obtaining patterns (i.e., anticipates purchasing extra instruments), and buying standards.
Drivers
Expanding business accessibility of new applications including multiomics (e.g., ATAC-seq, CITE-seq) and practical measures
10X Genomics driving extra applications on huge and developing introduce base
Enormous scope, all around financed drives, similar to the Human Cell Atlas
Pharma interest in single-cell strategies to support drug revelation (e.g., Takeda, Kite Pharma, and Janssen all have an organization with single-cell organizations)
New instruments (e.g., S2 Genomics’ Singluator) that can computerize and streamline the strong tissue to cells/cores suspension arrangement, taking care of high-throughput machines
Key Moderators
Mediators
Challenges in information examination and information joining as the interest in single-cell multiomics develops
High sequencing cost comparative with earlier logical advances
Absence of awareness as entire transcriptome moves toward just catch a piece of the complete communicated qualities
Restricted transient clinical applications
Client
Purchasers of SCG instruments, reagents, and consumables from producers
The scholarly world
Biopharma
Clinical
Applied Markets
Others
Field-of-Study
Sort of a stage that producer offers to its clients, in light of all through
Microbial science
Essential cell science
Immature microorganism science
Oncology
Immunology
Vague
Other
Topography
Country/district of the world
U.S.
Europe
Japan
China
Asia Pacific (APAC)
Rest-of-the-world (ROW)
Work process
Individual strides in the SCG examination process beginning from test and finishing with information
Single cell confinement
Test arrangement
Genomic examination
Application
Key logical exploration question being examined
Subpopulation portrayal
Genomic variety
Cell separation/reconstructing
Strategy
Coursing cells
Others
Organization
Organizations that offer SCG items
10X Genomics
1CellBio
BD
Berkeley Lights
Bio-Rad
Celsee
Dolomite Bio
Illumina
Mission Bio
Takara Bio
Fluidigm
Others
Scientific Technology
Genomic innovation used to measure and/or distinguish the DNA/RNA of each single cell
qPCR
Sequencing
PCR
Different
Microarray
Other
Item Type
Kind of item that maker offers to its clients
Instruments
Reagents